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Objectives. The purpose of this prospective study was to test the
hypothesis that the ellsoination of inducible
ular (AV) node recalry despite the persistence of slow AV pathway
conduction is a valid end point for radloilrequency catheter
ahlation procedures in paticaN with supraventricular lachyeardil
due to iV node reentry .
Daekgrouad. Although modification or AV node physiology by
radiofrequency current can eliminate At aade 4veakraad lachy-
cardfig, therapeutic chid points that are dermilive of a satisfactory
result in patients undergoing modification of the slow AV pathway
have not been estabUshed . Applications of radiofrequency current
at selected sites may eliminate all evidence of slow pathway
conduction or sufficiently modify the refractory properties of the
slow pathway to preclude sustained arrhythmias . Accordingly,
total abolition of dual AV node physiology may not be necessary to
prevent arrhythmia recurrence .
Methods . Radiofrequency catheter oblation of the slow AV
pathway was attempted in 59 patients with typical A% made
reentry . Tissue ablation was performed with a continuous wave of
Modification of dual atrioventricular (AV) node physiology
by the application of k -adiofrequency current to atrial tissue
near the AV node provides an important therapeutic alter-
native to pharmacologic or surgical therapy fer the treatment
of supraventricular tachycardia due to AV node reentry
(1-5) . The major risk of this procedure is inadvertent AV
conduction block, which may occur when radiofrequency
current s applied too close to the AV node . The risk of
heart block may be increased when attempts to completely
eliminate dual AV node physiology become protracted and
result in repetitive applications of radiofrequency current
along the tricuspid annulus, especially when energy is deliv-
ered close to the junction of the AV node and His bundle .
Moreover, difficult procedures often require prolonged use
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W-k1-1z rafflofrequency current. Twenty-five to 35 W was applied
for 60 s at the 41v selected for tissue destruction .
Residft . Dank AV node,physiology was eliminated completely in
35 patients (59%), persisted without inducible AV node reentry in
13 patients (22%) and persisted with inducible single AV reen-
trant beats its I I patients (19%) . In patients with persistent dual
AV node physiology, the maximal difference between the effective
rcfrmlory period oTthe fast and slow pathways was reduced from
104 It 62 ms before the procedure to 37 ± 37 ins after AV
conduction had been modified (p < 0.001). During a mean
follow-up interval of 15 months (range 4 to 25), only ore patient
(2%) had a recurrence of the tachycardia .
Conclusions. Results demonstrate that when complete eflanina-
lion of dual AV node physiology is difficult, modification of slag
pathway conduction to the extent that repetitive AV node reentry
cannot he induced is a definitive end point that portends a gscO
prognosis.
(J Am Coil Cardiol 1993,22133-40)
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of fluoroscopy and reduce the efficiency of facilities in
centers that perform a large number of electrophysiologic
studies (6,7) .
The therapeutic end points that portend a satisfactory
result in patients undergoing modification of the slow AV
pathway have not been established. Radiofrequency cur-
rent applications along the tricuspid annulus at the site
of presumed slow pathway potentials may eliminate all
evidence of slow pathway conduction or sufficiently modify
the refractory properties of the slow pathway to preclude
sustained arrhythrnias. Thus, modification of AV node
physiology may be sufficient to prevent a recurrence of
symptoms in patients in whom complete elimination of dual
AV node physiology is difficult and in whom persistent
attempts to abolish all evidence of slow AV conduction may
be harmful. Accordingly, the purpose of this study was to
prospectively determine the extent to which the inability to
induce repetitive AV node reentry irrespective of the pres-
ence or absence of dual AV node physiology is a valid
therapeutic end point for radiofrequency catheter ablation
procedures in patients with AV node suprasrentricular tachy-
cardia.
0735-1097793I%.00
Data are expressed as number (%) of patients . mean value SD. arrange .
Methods
Statly patients. Fifty-nine patients with AV node reentry
who were referred to Barnes Hospital for evaluation of
supraventricular tachycardia underwent a diagnostic clectro-
physiologic study and modification of AV node physiology
during a single procedure. The protocol was approved by the
Human Studies Committee (September 21, 1990) and in-
formed consent was obtained . The clinical characteristics of
the patients studied are summarized in Table 1 . All patients
had typical AV node reentry with slow anterograde and fast
retrograde conduction . There were 18 male and 41 female
patients, ranging in age from 12 to 77 years . The majority of
patients had no other evidence of heart disease . Two pa-
tients, who had both orthodromic supraventricular tachycar-
dia and AV rode reentry, underwent ablation of an acces-
sory pathway and modification of the AV node during the
same procedure . Before the ablation procedure, clinical
episodes of supraventrie ular tachycardin occurred fre-
quently in the majority of patients .
hysiologic studs . Patients were sedated with
midazolam and morphine. Catheters were positioned in the
right atrium, at the AV junction to record a His bundle
electrogram, within the coronary sinus and at the right
ventricular apex . The stimulation protocol included incre-
mental atria] and ventricular pacing, assessment of AV
conduction during the introduction of single atrial extrastim-
uh at paced cycle lengths of 700, 600, 500 and 400 ms and the
use of single ventricular extrastimuli. The criterion for
diagnosing dual AV node physiology was an increase in the
AH interval of >50 ms in response to a 10-ms decrease in the
coupling interval of the atrial extrastintulus (8) .1f sustained
supraventricular tachycardia was not induced, iseproterenol
(I to 4
4min) was infused to achieve a heart rate of 120 to
130 beatslmin .
ueny a p ure. Figure: I illustrates
the
region along the tricuspid annulus between the os of the
c sinus and the His bundle where presumed slow
pathway potentials were identified and radiofrequency cur-
rent was applied
. In cases where slow pathway potentials
were not identified, radiofrequency current ': vas applied
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Figure 1 . Schematic view of the heart demonstrating the region
along the tricuspid annulus between the os of the coronary sinus and
the His bundle where presumed slow pathway potentials were
detected and radiofrequency current applied . Radiofrequency cur-
rent was rarely applied in the upper third of the hatched region .
empirically within this region and the response to pro-
grammed stimulation was evaluated after each application .
The objective of this procedure was to eliminate the slow
pathway. Itadiofrequency current was applied through a
catheter with a 4- or 5-mm distal electrode . Tissue ablation
was performed with a continuous wave of 500-kHz radio-
frequency current . A control unit was used to select the
duration and voltage of the application and monitor voltage,
current and impedance. Twenty-five to 35 W was applied for
approximately 60 s at the site selected for tissue destruction .
Immediately after the application of radiofrequency cur-
rent, programmed atria] stimulation was performed to deter-
mine whether dual AV node physiology had been eliminated
as evidenced by continuous AV node conduction curves and
absence of AV node reentry. In patients who had persistent
dual AV node physiology despite repeated applications of
radiofrequency current, the procedure was concluded when
repetitive AV node reentry had been eliminated . One hour
after a therapeutic end point had been achieved, pro-
grammed stimulation was repeated to confirm that functional
slow pathway physiology had not recovered . If repetitive
AV node reentry could not be induced, isoproterenol was
infused at a rate of I to 4 , ag/min to achieve a heart rate at
rest of 120 to 130 beatstmin and programmed atrial stimula-
tion was repeated.
Patients were generally discharged from the hospital the
day after the electrcphysiologic study and were seen for
follow-up I to 3 months after the procedure . Late follow-up
was obtained for each patient by a direct telephone inter-
view.
Statistical analysis. Data are presented as the mean va`ue
± SD and were compared between groups by an unpai •ed
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Table 1
. Characteristics of the 59 Study Patients
Male/female
18141
Age (yr)
Mean
44 ± 18
Range
12 to 77
Other heart disease
None
51
tschemic heart disease
6
Nonischemic heart disease
2
Spontaneous supraventricular lachycardia
Every I to 7 days
24(41)
Every 1 to 4 weeks
12 (20)
Every 1 to 3 months
1505)
Every 3 toe months
8(14)
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Table 2 . Results of Elect roph ysiologic Studies
Data are presented as mean value ± SD or number (%o) of patients . AV =
atriovetridculat ; CL = cycle length .
i test and within groups with a paired t test . The Fisher exact
test was used to compare the percent of conduction curves
that exhibited evidence of dual AV node physiology before
compared with after the ablation procedure . A significant
difference was considered to exist when p < 0 .05 .
Regression analysis of AV node conduction was per-
formed using data acquired before and after the procedure at
a paced cycle length of 600 no . Conduction through the fast
AV pathway typically exhibited little change in the AH
interval at long coupling intervals, but at shorter coupling
intervals the AH interval prolonged before block occurred in
the fast pathway . For each patient, thee slope of the regres-
sion line of fast pathway cot . .ction was determined over
the range of coupling intervals that exhibited decremental
conduction . Results obtained before the procedure were
compared with those obtained after modification of AV node
physiology using t tests . The slope of the regression line of
the slow pathway was also determined over the range of
coupling intervals that exhibited conduction through the
slow pathway with a linear increment in the AH interval .
Results
Observed changes in dual
AV node physiology . A mean of
18 ± 12 applications of radiofrequency current was delivered
during the procedure
. Table 2 summarizes the observed
changes in AV node physiology . For the entire group of
patients, there was no significant change in the AH interval,
the cycle length at which AV node Wenckebach conduction
was first observed or the HV interval . On the basis of the
response to programmed atrial extrastimuli, AV node con-
duction was discontinuous in 55 patients (93%) at the begin-
ning of the study. Discontinuous AV node conduction was
detected in 24 (41%) of the patients after all attempts to
ablate the slow pathway . Single AV node echo beats were
induced in all 59 patients it the beginning of the study and in
I I patients (19%) after the ablation procedure was per-
formed
. Sustained AV node reentrant tachycardia was in-
duce. in 56 patients (95%) beforee the application of radio-
frequency current
. Six patients required an infusion of
isoproterenol to induce sustained AV node reentry .
A mean of 8 ± 7 episodes of sustained AV node
reentry
LINDSAY ET AL .
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(range 0 to 35) was induced before attempted ablation of the
slow pathway
. No patient had an inducible tachycardia or
more than a single AV node reentrant beat after the slow
pathway had been ablated or modified (p < 0
.000 .
Analysis of the response to programmed atrial enastim-
uh was based on data acquired at the beginning and conclu-
sion of the study at paced cycle lengths of 700, 600, 500 or
400 ms
. Not all cycle lengths could be evaluated in each
patient because of individual variability in rest heart rate,
exclusive conduction through the fast or slow pathway at all
coupling intervals and the cycle length at which AV node
Wenckebach conduction was observed
. Accordingly, the
number and percent of paced cycle lengths tested in patient
groups that demonstrated dual AV node physiology before
the ablation procedure were compared with results obtained
after the procedure . Patients in whom &al AV node physi-
ology was eliminated had evidence of dual AV node physi-
ology in 68 (86%) of 79 paced cycle lengths tested in the
initial portion of the study compared with f of 82 paced cycle
lengths tested at the conclusion of the study (p < 0 .0001) . In
the patients with residual dual AV node physiology, evi-
dence of dual AV node physiology was detected in 53 (92%)
of 57 paced cycle lengths tested at the initial portion of the
study compared with 40 (68%) of 59 cycle lengths tested at
the conclusion (p = NS) .
Table 3 summarizes the response to programmed atrial
stimulation before and after the ablation procedure in pa-
tients in whom dual AV node physiology was completely
eliminated and in those in whom dual AV node physiology
persisted . Initial recordings were made before the applica-
tion of radiofrequency current or infusion of isoproterenol
.
Final recordings were made I h after the therapeutic end
point had been reached and before isoproterenol was in-
fused. The maximal increment in the Al-I interval in response
to a 10-ms decrement in the airial coupling interval, the AH
jump, was determined at several paced cycle lengths in each
patient . The maximal AH jump was used for patient to
patient comparison
. There was no significant difference in
the magnitude of the AH jump before the ablation procedure
in patients who ultimately had complete elimination of dual
AV node physiology (94 ± 55 ms) compared with those who
had persistent dual AV node physiology (95 ± 44 ms) .
Moreover, for the latter patients, there was no significant
difference in the magnitude of the AH jump before (95 ±
44 ms) compared with after (100 ± 60 ms) modification of the
slow AV node pathway .
Effective refractory periods
. The difference between the
effective refractory period of
the slow and fast pathways was
also compared
. This difference represents the interval during
which AV node reentry is likely to be induced
. For each
patient, the maximal difference between effective refractory
periods of the fast and slow pathways measured at several
paced cycle lengths was used for patient comparisons
. Table
3 compares the maximal difference in the effective refractory
periods of the fast and slow AV pathways at all cycle lengths
tested, as well as the difference at specific paced cycle
E
;ectrophysi0ogic Characteristics preablation postablafion
AN interval (ms) 95±16 82 16
HV interval (ms)
49¢8 5)±8
W=ckcWch CL (au) 356 5f,. 362 ± 59
AV W wn&oba
Discontinuous 55t93) 24(41)
Continuous 4 (7)
35 (59)
Single AV node echo beat 59 (100)
11(19)
Sustained AV node reentrant tachycaudia
, (95)5e
0
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Table 3
.
Effects of Procedure on Dual Atrioventricular
Node Physiology
p values listed in the left column compare initial with final results ; p values
in the right column compare results in patients who had dual atrioventricular
(AV) node physiology eliminated with those of patients in whom it persisted .
Data are presented as mean value ± SD . ERP
:
effective refractory period ;
PCL - paced cycle length .
lengths before and after the procedure . At paced cycle
lengths of 700 and 400 ms, there was a significant decrease in
this difference at the conclusion of the procedure compared
with initial results in patients with residual dual AV node
physiology . There was a similar trend at paced cycle lengths
of 500 and 400 ms . There were no significant differences in
these values before the ablation procedure between patients
in whom dual AV node physiology was eliminated and those
in whom it persisted .
The effective refractory periods of the fast and slow AV
pathways were determined, when possible, at several paced
cycle lengths before and after attempted ablation of the slow
pathway . Results of analysis (Table 4) demonstrated that the
effective refractory period of the fast pathway was
,signifi-
cantly shorter at the conclusion of the procedure in patients
without persistence of dual AV node physiology . In patients
with residual dual AV nodal physiology, the effective refrac-
tory period was significantly shorter at paced cycle lengths
of 700 and 600 ms, and this trend was present at paced cycle
lengths of 500 and 400 ms . In patients with persistent dual
AV node physiology, the effective refractory period of the
9ACC Vol . 22, No . 3
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Table 4. Effect of Procedure on Effective Refractory Periods of
the Fast and Slow Pathways
p values listed itn the left column compare initial with final results ; p values
in the right column compare results in patients who had dual atrioventricular
(AV) node physiology eliminated with those of patients in whom it persisted .
Data are presented as mean value t SD . Abbreviations as in Table 3 .
slow pathway was significantly longer at a paced cycle length
of 600 ms but not at the other cycle lengths tested .
Results of regression analysis demonstrated that as a
consequence of the procedure, the slope of the fast pathway
increased significantly in patients who had complete elimi-
nation of dual AV node physiology (p = 0.017), as well as
those in whom AV node conduction remained discontinuous
without reentry (p = 0.034) and those with residual single
echo beats (p = 0 .024). The slopes of the fast AV pathway
conduction did not differ significantly among these groups,
nor was there any significant difference among groups in the
magnitude of change of slope before compared with
after
the
procedure . A similar analysis was performed for the slope of
conduction through the slow pathway . There was no signif-
icant difference in the slope of slow pathway conduction
before compared with after the procedure in patients with
Dual Physiology
Eliminated
Dual Physiology
Persisted p Value
Fast pathway (ms)
PCL 700 ms
Initial 466 ± 91 466 ± 79 NS
Final 352 ± 42
357 -±° 36 NS
p value 0.001 0.003
PCL 600 ms
Initial 393 ± 102 411 ± 96 MS
Final 355 ± 68 353 ± 66 NS
p value 0.001 0.038
PCL 500 ms
Initial
364 ± 72
356 ± 63 NS
Final 304 ± 33 295 t 72 NS
p value 0.043 0.086
PCL 400 ms
Initial 3141 t 49 325 ± 28 NS
Final 274 ± 56 303 ± IS NS
p value 0,015 0
. 1,
Slow pathway (ms)
PCL 700 ms
Initial 281 ± 52 311 ± 27 NS
Final - 311 ± 18
p value NS
PCL 600 ms
Initial 28,) t 50 278 ± 44 NS
Final 311 ± 62
p value 0 .045
PCL 500 ms
Initial 3(14 *_ 29 287 ± 47 NS
Final m- 260 ± 49
p value -- 0 .131
PCt . 400 n1s
Initial 259 ± 41 268 ± 8 NS
Final - 276 ± 31
p value --
0 .578
Electrophysiologic
Characteristics
Dual Physiology Dual Physiology
Eliminated
Persisted p Value
Maximal AH jump (ms)
Initial
94 ± 55
95 ± 44 NS
Final
I00 ± 60
p value
Difference between ERP of
fast and slow AV
pathways (ms)
Maximal
Initial
123 ± 85
NS
104 ± 62 NS
Final
37 ± 37
p value < 0 .001
PCL 700 ms
Initial 164 ± 80
143 t 73 NS
Final
40 ± 20
p value 0 .01
PCL 600 ms
Initial III t 93
105 ± 64 NS
Final -
38
.
:28
p value 0,019
PCL 500 ms
Initial
88 ± 58 81 ± 28 NS
Final
45 ± 33
p value
0.113
PCL 400 ms
Initial
60 ± 29 52 ± 31 NS
Final 22 ± 25
-p value 0.23
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A1A2 COUPLING INTERVAL (ms)
Figure 2. Atrioventricular node conduction curves demonstrating
complete elimination of dual AV node physiology . The response to
programmed and[ stimulation before (open squares) the ablation
procedure demonstrated a discontinuity of 145 ins and conduction
through the slow AV pathway was associated with reproducible
induction of AV node reentrant supraventricular tachycardia
(arrows) . After the ablation procedure (closed diamonds), AV node
conduction was continuous and reentry was not induced .
residual dual AV node physiology . At the conclusion of the
procedure, the slopes of slow pathway conduction did not
differ between the group that had residual dual AV node
physiology and the group without single reentrant echo
beats, nor was there any difference between these groups in
the magnitude of the change in slope .
Characteristic responses to atrial stimulation . Three pat-
terns of responses of the AY node to programmed atrial
stimulation were observed after the ablation procedure . All
evidence of dual AV node physiology was eliminated in 59%
of the patients . Representative AV node conduction curves
before and after the procedure from a patient having this
pattern of response are shown in Figure 2 . In the second
pattern, dual AV node physiology persisted, but reentry was
not induced . This pattern was observed in 22% of the
patients studied (Fig . 3). Moreover, in this group, the
difference between the effective refractory periods of the fast
and slow pathways decreased after the ablation procedure .
In the third pattern, observed in 19% of the patients, dual
AV node physiology persisted and single AV node reentrant
(echo) beats were induced (Fig . 4) . In patients with residual
echo beats, the response to a sufficiently premature atrial
extrastimulus was characterized by anterograde conduction
through the slow pathway and retrograde conduction
through the fast pathway with a short HA interval, followed
by AV block in the slow pathway (Fig . 5) . This response
suggests that radiofrequency current modified the refractory
properties of the slow AV pathway to an extent that pre-
cluded repetitive conduction, which would be required to
sustain AV node reentry.
I
4X
w
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Figure 3
. Persistence of discontinuous AV node conduction without
reentry
. The response to programmed atrial sti .itilation before (open
squares) the ablation procedure exhibited a discontinuity of 80 ms
and conduction through the slow AV pathway resulted in sustained
AV node reentrant supraventricular tachycardia (arrows) . After
1110dificalion
of the slow pathway (closed diamonds) . AV node
conduction efl0ited a discontinuity of 85 ms, the difference be-
tween fast and slow pathway refractoriness was reduced from 70 to
20 ins and reentry was not induced .
Follow-up. Table 5 summarizes the clinical course of the
59 patients during a mean follow-up period of 15 ± 6 months
(range 4 to 28) . No patient had a documented recurrence of
supraventricular tachy cardia . One patient, in whom dual AV
Figure 4 . Persistence of discontinuous AV node conduction with
single reentrant beats
. Before ablation, AV node conduction (open
squares) showed a discontinuity of 175 no and conduction through
the slow pathway resulted in sustained supraventricular tachycardia
(arrows)
. After the slow pathway had been modified (closed dia-
monds), a discontinuity of 80 ms was observed and single AV node
echo beats were induced (star)
. The difference between the refrac-
tory periods of the fast and slow pathways was reduced from 60 to
30 ms .
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Figure S . Representative recording of residual dual AV node phys-
iology with a single retrograde atria) echo beat (AVN ECHO) at the
conclusion of the prxedure . Anterograde AV conduction occurs
through the fast AV pathway at a paced cycle length of 600 His .
Anterograde conduction occurs through the slow AV pathway in
response to a premature atrial extrastimulus and is followed by
retrograde conduction over the fast AV node pathway . CS =
coronary sinus ; DIST = distal ; HBE His bundle electrogram,
HRA = high right atrium ; PROX proximal ; RVA = right
ventricular apex,
node physiology had been eliminated, has experienced over
a period of 1 year three episodes of palpitation, lasting up to
10 min, that were very similar to the symptoms she experi-
enced daily before the ablation procedure . This patient
declined to undergo follow-up study . If one assumes that
these symptoms represented AV node reentry, the recur-
rence rate for the entire group was 2%. None of the patients
with persistent dual AV node physiology have had a recur-
rence of supraventricular tachycardia. There was no differ-
ence between the recurrence rate for patients with (0 of 24)
Table 5 . Results of Follow-Up Study
Data are expressed as number
(%) of patients, mean value ± SD or range
.
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and that of patients without (I of 35) residual dual AV node
physiology . There was no significant difference in the length
of the follow-up interval for patients who had complete
elimination of dual AV node physiology and that of patients
with persistent evidence of dual AV node physiology .
Complications. Three patients developed symptomatic
AV node Wenckebach block within 24 h of the ablation
procedure. We conclude that the fast pathway was damaged ;
however, this effect was not apparent at the end of the
procedure . None of these patients exhibited prolongation of
the effective refractory period of the fast pathway ; the paced
cycle length at which AV Wenckebach block occurred was
unchanged and retrograde conduction remained intact . In
each case, radiofrequency current had been applied rela-
tively close to the AV node-His bundle junction . Conduc-
tion returned to normal in two of the patients within a few
days and no intervention was required . In the third patient,
symptomatic AV node Wenckebach block at rest persisted
even though AV conduction was intact during exercise . A
permanent pacemaker was implanted 3 months after the
ablation procedure. Two other patients have had inappropri-
ate sinus tachycardia at rest . These patients had normal
findings on electrocardiogram, echocardiogram, erythrocyte
sedimentation rate and chest X-ray study. Neither patient
had chest pain or objective evidence of pericarditis . In-
appropriate sinus tachycardia has persisted for months and
has required treatment with low doses of beta-adrenergic
antagonists. The patients who developed AV conduction
abnormalities or inappropriate sinus tachycardia had each
received >20 applications of radiofrequency current .
Discussion
Development of procedures to eliminate AV node reentry .
In 1971 Pritchett et al . (9) reported that during attempted
surgical dissection of the His bundle in a patient with
incessant AV node reentry, the tachycardia was abolished
and sinus rhythm with normal AV conduction was pre-
served. This fortuitous result demonstrated the feasibility of
modifying the substrate required for AV node reentry as a
curative procedure. Subsequent studies in experimental
animals and the surgical experience in humans established
that at least a portion of the tissue that mediates AV node
reentry resides outside the anatomic confines of the AV node
(10-15). The success of cryothermal lesions around the
triangle of Koch in preventing AV node reentry was often
associated with ablation of the slow AV pathway (14,15) .
Although the precise location of tissue that mediated slow
AV conduction was not identified intraoperatively, results of
clinical electrophysiologic studies (2-5,16,17) have sug-
gested that atrial tissue near the os of the coronary sinus is
responsible for the phenomenon of slow AV pathway con-
duction .
Results obtained intraoperatively and in the electrophys-
iology laboratory have provided the basis for modification of
AV node physiology by energy delivered from catheters
Group
No . of
Patients
Months of
Follow-Up
(mean ; range)
Patients With
Arrhythmia
Recurrence
Dual AV no c physiology
cifina"med
Dual AV n(Ae physiology
persisted
35(59) 15 ± 6 ; 4 to 28 1(3)
No reentry
13 (22) 17 ± 7,4 to 28 0
Single AV node echo beat
11 (IT 0 ± 16W 21 0
Combined 59 IS ±Q4toN 1(2)
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introduced percutaneously with electrodes positioned near
the AV node . The early experience with modificatior, of AV
node physiology by delivering direct current shocks proxi-
mal to the region where optimal His burdle electrograms
were recorded resulted in apparent ablation or modification
of the fast AV node pathway and was associated with a 10%
risk of inducing complete heart block (18,19) . Additional
experience with radiofrequency current has improved the
efficacy of this approach and the risk of inducing complete
heart block has decreased (20) .
The possibility that slow AV pathway conduction could
be altered by ablating tissue remote from the anatomic AV
node-His bundle junction attracted interest because it of-
fared promise for reduced risk of inducing AV block . Several
groups (2-5) have established that selective ablation of the
slow AV pathway can be accomplished by applying radio-
frequency current near the tricuspid annulus between the os
of the coronary sinus and the His bundle, where presumed
slow pathway potentials are recorded . In some patients, this
effect is achieved easily, but in others complete elimination
of dual AV node physiology is difficult . Repeated attempts to
abolish all evidence of dual AV node physiology may result
in a large number of applications of radiofrequency current
near the AV node, which increases the risk of inducing
second- or third-degree AV block or inappropriate sinus
tachycardia, increases fluoroscopy time and prolongs the
entire procedure .
In the present study, we attempted to eliminate slow AV
conduction, but hypothesized that modification of the refrac-
tory properties of this tissue might suffice to prevent a
clinical recurrence of the tachycardia . Results of electro-
physiologic testing conducted 1 h after completion of the
ablation procedure demonstrated discontinuous AV node
conduction curves without evidence of reentry in 22% of
patients . Patients who exhibited this response were catego-
rized as having residual dual AV node physiology based on
the established criterion of an increment in the AH interval
of 50 ms in response to a 10-ms decrement in the A1A2
coupling interval. There are no established criteria that
differentiate this response from decremental conduction
through the fast pathway. The absence of AV node echo
beats in patients who exhibited this response raises the
possibility that the slow pathway had been ablated . How-
ever, the magnitude of the increment in the AH interval (AH
jump) before compared with after the procedure was not
significantly changed in these patients . The difference be-
tween the effective refractory periods of the fast and slow
pathways, which represented the range of coupling intervals
at which reentry could occur, was significantly decreased .
These changes may have altered the properties of the
reentrant circuit sufficiently to prevent retrograde conduc-
tion through the fast pathway at coupling intervals when
anterograde conduction through the slow pathway could be
demonstrated .
Discontinuous AV node conduction curves with single
reentrant beats that blocked anterogradely in the slow AV
LINDSAY ET AL .
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pathway were observed in
197o of the patients . In the
patients who exhibited single AV node reentrant beats, the
difference between slow and fast pathway refractoriness was
reduced . This difference, which corresponds to the range of
coupling intervals during which spontaneous or programmed
atrial extrastimuli are likely to induce AV node reentry, was
primarily attributable to shortening of the effective refrac-
tory period of the fast pathway . Although the effective
refractory period of the slow pathway was not changed by
the procedure, the protocol assessed the response to single
atrial extrastimuli . Further study might evaluate the re-
sponse to multiple atrial extrastimuli . We conclude that
repetitive conduction through the slow pathway was affected
and that this was the reason that repetitive AV node reentry
was not induced .
Although the objective of this study was to selectively
ablate or modify the slow AV pathway, the response to
programmed atrial stimulation at the conclusion of the study
demonstrated shortening of the effective refractory period of
the fast pathway at several paced cycle lengths . There was
no -significant change in the AH interval at rest before
compared with after the procedure, nor was there a change
in the paced cycle leng' h at which AV node Wenckebach
block was observed . Moreover, retrograde conduction re-
mained intact in all patients studied . At the conclusion of the
study, however, the response to programmed atria] stimula-
tion demonstrated shortening of the effective refractory
period of the fast pathway at several paced cycle lengths .
These results suggest that the function of the fast pathway is
affected by the presence of the slow pathway Shortening of
the effective refractory period and increased slope of the
conduction curve of the fast pathway may reflect an alter-
ation of parasympathetic or sympathetic innervation of the
AV node or functional interactions may exist between the
two pathways.
A mean of 18 t 12 applications of radiofrequency current
was applied in this study . One limitation of the technology
employed at the time these patients were studied was that
we could not determine whether ineffective applications
were not optimally positioned with respect to the location of
the slow pathway or whether tissue contact was inadequate .
The use of thermistor catheters may resolve this issue in the
near future . One reason that the number of lesions applied
was relatively high is that we attempted to eliminate all
evidence of dual AV node physiology . Our impression is that
repetitive AV node reentry can often be eliminated by
relatively few applications of radiofrequency current at the
site of presumed slow pathway potentials . Attempted elim-
ination of all evidence of dual AV node physiology increases
the number of lesions and appears to be unnecessary . We are
concerned that the risk of complications may increase with
the numb,r of radiofrequency current applications, but the
results of this study do not define a minimal or maximal
number of applications that AwAd be attempted during an
ablation procedure .
A salient feature of the protocol employed in this study
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was that final testing was deferred for 1 h after the therapeu-
tic end pout had been achieved . The time course of recovery
of slow pathway function was not studied systematically, but
it was frequently observed during the 1st 30 min after
applications of radiofrequency current and often prompted
additional attempts to eliminate or modify the slow AV
pathway. We also observed that dual AV node physiology
was occasionally evident at one but not at other paced cycle
lengths . Protocols that restrict the interval between applica-
tions of radiofrequency current and testing or evaluate the
response to programmed atrial extrastimuli at only a single
paced cycle length might obtain different results .
Limitations of the study . One limitation of this investiga-
tion was that a follow-up study was not performed . It would
have been of interest to determine whether the immediate
effects of the procedure on dual AV node physiology were
concordant with the long-term effects . We chose not to
perform a follow-up study, however, because the primary
objective of the procedure was to eliminate symptoms . This
study, which includes a mean follow-up interval of IS
months, demonstrates a successful long-term result . It is
highly unlikely that results of a follow-up study would alter
that conclusion . Moreover, other investigators (1,2) have
reported little change in AV node physiology during follow-
up, and it is difficult to justify an invasive follow-up proce-
dure for asymptomatic patients whose prior arrhythmias
were not life-threatening.
Clinical implications . The results of this study have im-
portant implications for electrophysiologists who perform
ablation procedures for patients with AV node reentry .
Protracted attempts to eliminate single AV node reentrant
beats are unnecessary. Moreover, we are concerned that the
risk of complications is related not only to the site at which
radiofrequency current is applied, but also to th, , cumulative
energy employed during the procedure . W .' ,,, , n complete
elimination of dual AV node physiology is not easily accom-
plished, single AV node reentrant beats in response to
programmed atrial stimulation represent a satisfactory ther-
apeutic end point and portend a low risk for recurrence of
the clinical tachycardia in patients whose arrhythmia was
easily inducible before radiofrequency current was applied .
We appreciate the technical assistance of H .
Dieter Ambos, Joseph E . Loslo
and Dennis G . Fogarty, RN during the ablative procedures and thank Yvonne
O'Connell for preparation of the manuscript,
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